Filing Details

Accession Number:
0001209191-17-021497
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-17 17:29:39
Reporting Period:
2017-03-16
Filing Date:
2017-03-17
Accepted Time:
2017-03-17 17:29:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1513818 Versartis Inc. VSAR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1380178 Shahzad Malik C/O Advent Life Sciences
158 North Gower Street
London X0 X0 NW1 2ND
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-03-16 97,303 $18.50 2,007,925 No 4 S Indirect See footnote
Common Stock Disposition 2017-03-17 386,367 $18.01 1,621,558 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
No 4 S Indirect See footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 9,200 Direct
Footnotes
  1. The shares were sold at prices ranging from $18.30 to $18.70. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  2. Securities are held by Advent Life Sciences LLP ("Advent") and Advent Life Sciences Fund I LP ("Advent Fund"). Advent is the general partner of Advent Fund. The Reporting Person is a partner of Advent, and disclaims beneficial ownership of the shares held by Advent or the Advent Fund except to the extent of his indirect pecuniary interest therein.
  3. The shares were sold at prices ranging from $18.00 to $18.48. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.